𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance

✍ Scribed by Leung, E L; Fraser, M; Fiscus, R R; Tsang, B K

Book ID
121817185
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
170 KB
Volume
98
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Akt promotes cisplatin resistance in hum
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
✍ Michael Fraser; Tao Bai; Benjamin K. Tsang πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 736 KB

## Abstract Resistance to cisplatin‐based chemotherapy is a major cause of treatment failure in human ovarian cancer. Wild‐type __TP53__ status is often, but not always, associated with cisplatin sensitivity, suggesting that additional factors may be involved. Overexpression/activation of the phosp

Nitric oxide synthase gene therapy enhan
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells
✍ Catherine Adams; Helen O. McCarthy; Jonathan A. Coulter; Jenny Worthington; Clai πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 206 KB

## Abstract ## Background Nitric oxide (NOΒ·) derived from donor drugs has been shown to be an effective chemosensitizer __in vitro__. We investigated the combination of inducible nitric oxide synthase (iNOS) gene transfer, driven by a strong constitutive promoter (cytomegalovirus; CMV) with the DN